Effect of dopamine transporter gene (SLC6A3) variation on dorsal anterior cingulate function in attention-deficit/hyperactivity disorder

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 153, Issue 2, 2010, Pages 365-375

  Brown, Ariel B ^a,b   Biederman, Joseph ^a   Valera, Eve M ^a   Doyle, Alysa E ^a   Bush, George ^a   Spencer, Thomas ^a   Monuteaux, Michael C ^a   Mick, Eric ^a   Whitfield Gabrieli, Susan ^c   Makris, Nikos ^a,d   LaViolette, Peter S ^a   Oscar Berman, Marlene ^b,e   Faraone, Stephen V ^f   Seidman, Larry J ^a,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e DEPARTMENT OF VETERANS AFFAIRS   (United States)

^f State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

adhd; Anterior cingulate; Dopamine transporter gene; Functional magnetic resonance imaging; Genetics

Indexed keywords

3' UNTRANSLATED REGION; ADOLESCENT; ADULT; ALLELE; ARTICLE; ATTENTION DEFICIT DISORDER; CEREBELLUM VERMIS; CINGULATE GYRUS; CLINICAL ARTICLE; COGNITION; DNA POLYMORPHISM; ELECTROENCEPHALOGRAM; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HETEROZYGOTE DETECTION; HOMOZYGOSITY; HUMAN; MALE; PREFRONTAL CORTEX; PRIORITY JOURNAL; TANDEM REPEAT;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COGNITION; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENETIC VARIATION; GENOTYPE; GYRUS CINGULI; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MODELS, NEUROLOGICAL; RISK;

EID: 77349095035     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31022     Document Type: Article

References (59)

1. Bertolino A, Blasi G, Latorre V, Rubino V, Rampino A, Sinibaldi L, Caforio G, Petruzzella V, Pizzuti A, Scarabino T, et al. 2006. Additive effects of genetic variation in dopamine regulating genes on working memory cortical activity in human brain. J Neurosci 26(15):3918-3922.
2. Boonstra AM, Kooij JJ, Buitelaar JK, Oosterlaan J, Sergeant JA, Heister JG, Franke B. 2008. An exploratory study of the relationship between four candidate genes and neurocognitive performance in adult ADHD. Am J Med Genet Part B 147B(3):397-402.
3. Booth JR, Burman DD, Meyer JR, Lei Z, Trommer BL, Davenport ND, Li W,Parrish TB, Gitelman DR,MesulamMM.2005. Larger deficits in brain networks for response inhibition than for visual selective attention in attention deficit hyperactivity disorder (ADHD). J Child Psychol Psychiatry 46(1):94-111.
4. Bush G, Shin LM. 2006. The multi-source interference task: An fMRI task that reliably activates the cingulo-frontal-parietal cognitive/attention network. Nat Protoc 1(1):308-313.
5. Bush G, Frazier JA, Rauch SL, Seidman LJ, Whalen PJ, Jenike MA, Rosen BR, Biederman J. 1999. Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the counting stroop. Biol Psychiatry 45(12):1542-1552.
6. Bush G, Luu P, Posner MI. 2000. Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci 4(6):215-222.
7. Bush G, Shin LM, Holmes J, Rosen BR, Vogt BA. 2003. The multi-source interference task: Validation study with fMRI in individual subjects. Mol Psychiatry 8(1):60-70.
8. Bush G, Valera EM, Seidman LJ. 2005. Functional neuroimaging of attention-deficit/hyperactivity disorder: A review and suggested future directions. Biol Psychiatry 57(11):1273-1284.
9. Bush G, Spencer TJ, Holmes J, Shin LM, Valera EM, Seidman LJ, Makris N, Surman C, Aleardi M, Mick E, et al. 2008. Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task. Arch Gen Psychiatry 65(1):102-114.
10. Castellanos FX, Lee PP, Sharp W, Jeffries NO, Greenstein DK, Clasen LS, Blumenthal JD, James RS, Ebens CL, Walter JM, et al. 2002. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. J Am Med Assoc 288(14):1740-1748.
11. Castellanos FX, Margulies DS, Kelly C, Uddin LQ, Ghaffari M, Kirsch A, Shaw D, Shehzad Z, Di Martino A, Biswal B, et al. 2008. Cingulateprecuneus interactions: A new locus of dysfunction in adult attentiondeficit/hyperactivity disorder. Biol Psychiatry 63(3):332-337.
12. Dickstein SG, Bannon K, Castellanos FX, Milham MP. 2006. The neural correlates of attention deficit hyperactivity disorder: An ALE metaanalysis. J Child Psychol Psychiatry 47(10):1051-1062.
13. Durston S, Fossella JA, Casey BJ, Hulshoff Pol HE, Galvan A, Schnack HG, Steenhuis MP, Minderaa RB, Buitelaar JK, Kahn RS, et al. 2005. Differential effects of DRD4 and DAT1 genotype on fronto-striatal gray matter volumes in a sample of subjects with attention deficit hyperactivity disorder, their unaffected siblings, and controls. Mol Psychiatry 10(7): 678-685.
14. Durston S, Fossella JA, Mulder MJ, Casey BJ, Ziermans TB, Vessaz MN, Van Engeland H. 2008. Dopamine transporter genotype conveys familial risk of attention-deficit/hyperactivity disorder through striatal activation. J Am Acad Child Adolesc Psychiatry 47(1):61-67.
15. Eriksen BA, Eriksen CW. 1974. Effects of noise letters upon the identification of a target letter in a nonsearch task. Percept Psychophys 16:143-149.
16. Faraone S, Biederman J. 2005. What is the prevalence of adult ADHD? Results of a population screen of 966 adults. J Attention Disord 9(2): 384-391.
17. Faraone SV, Biederman J, Feighner JA, Monuteaux MC. 2000. Assessing symptoms of attention deficit hyperactivity disorder in children and adults: Which is more valid? J Consult Clin Psychol 68:830-842.
18. Faraone SV, Sergeant J, Gillberg C, Biederman J. 2003. The worldwide prevalence of ADHD: Is it an American condition? World Psychiatry 2(2):104-113.
19. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P. 2005. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57(11):1313-1323.
20. Fassbender C, Zhang H, Buzy WM, Cortes CR, Mizuiri D, Beckett L, Schweitzer JB. 2009. A lack of default network suppression is linked to increased distractibility in ADHD. Brain Res 1273:114-128.
21. First M, Spitzer R, Gibbon M, Williams J. 1997. Structured clinical interview for DSM-IV axis I disorders. Washington, DC: American Psychiatric Press. p 84.
22. Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG, Lee KS, Linnoila M, Weinberger DR. 2000. Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 22(2):133-139.
23. Jastak J, Jastak S. 1993. Wide range achievement test, 3rd edition. Wilmington, DE: Jastak Associates.
24. Kim JW, Kim BN, Cho SC. 2006. The dopamine transporter gene and the impulsivity phenotype in attention deficit hyperactivity disorder: A casecontrol association study in a Korean sample. J Psychiatr Res 40(8): 730-737.
25. Konrad K, Neufang S, Hanisch C, Fink GR, Herpertz-Dahlmann B. 2006. Dysfunctional attentional networks in children with attention deficit/hyperactivity disorder: Evidence from an event-related functional magnetic resonance imaging study. Biol Psychiatry 59(7):643-651.
26. Kooij JS, Boonstra AM, Vermeulen SH, Heister AG, Burger H, Buitelaar JK, Franke B. 2008. Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1). Am J Med Genet Part B 147B(2):201-208.
27. Krain AL, Castellanos FX. 2006. Brain development and ADHD. Clin Psychol Rev 26(4):433-444.
28. Krause J. 2008. SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder. Expert Rev Neurother 8(4):611-625.
29. Kronenberg G, Ende G, Alm B, Deuschle M, Heuser I, Colla M. 2008. Increased NAA and reduced choline levels in the anterior cingulum following chronic methylphenidate. A spectroscopic test-retest study in adult ADHD. Eur Arch Psychiatry Clin Neurosci 258(7):446-450.
30. Madras BK, Miller GM, Fischman AJ. 2005. The dopamine transporter and attention-deficit/hyperactivity disorder. Biol Psychiatry 57(11):1397-1409.
31. Makris N, Biederman J, Valera EM, Bush G, Kaiser J, Kennedy DN, Caviness VS, Faraone SV, Seidman LJ. 2007. Cortical thinning of the attention and executive function networks in adults with attentiondeficit/hyperactivity disorder. Cereb Cortex 17(6):1364-1375.
32. McNair DM, Lorr M, Droppelman LF. 1992. EdITS manual for the Profile ofMoodStates (POMS). San Diego, CA: EdITS/Education and Industrial Testing. Service.
33. Meyer-Lindenberg A, Weinberger DR. 2006. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci 7(10):818-827.
34. Mill J, Asherson P, Browes C, D'Souza U, Craig I. 2002. Expression of the dopamine transporter gene is regulated by the 3′ UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR. Am J Med Genet 114(8):975-979.
35. Monuteaux MC, Seidman LJ, Faraone SV, Makris N, Spencer T, Valera E, Brown A, Bush G, Doyle AE, Hughes S, et al. 2008.A preliminary study of dopamineD4receptor genotype and structural brain alterations in adults with ADHD. Am J Med Genet Part B 147B(8):1436-1441.
36. Oh KS, Shin DW, Oh GT, Noh KS. 2003. Dopamine transporter genotype influences the attention deficit in Korean boys with ADHD. Yonsei Med J 44(5):787-792.
37. Orvaschel H, Puig-Antich J. 1987. Schedule for affective disorders and schizophrenia for school-age children: Epidemiologic version. Fort Lauderdale, FL: Nova University.
38. Purper-Ouakil D, Wohl M, Orejarena S, Cortese S, Boni C, Asch M, Mouren MC, Gorwood P. 2008. Pharmacogenetics of methylphenidate response in attention deficit/hyperactivity disorder: Association with the dopamine transporter gene (SLC6A3). Am J Med Genet Part B 147B(8): 1425-1430.
39. Rommelse NN, Altink ME, Arias-Vasquez A, Buschgens CJ, Fliers E, Faraone SV, Buitelaar JK, Sergeant JA, Franke B, Oosterlaan J. 2008. A review and analysis of the relationship between neuropsychological measures and DAT1 in ADHD. Am J Med Genet B Neuropsychiatr Genet 147B(8):1536-1546.
40. Rubia K, Overmeyer S, Taylor E, Brammer M, Williams SC, Simmons A, Bullmore ET. 1999. Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: A study with functional MRI. Am J Psychiatry 156(6):891-896.
41. Schott BH, Seidenbecher CI, Fenker DB, Lauer CJ, Bunzeck N, Bernstein HG, Tischmeyer W, Gundelfinger ED, Heinze HJ, Duzel E. 2006. The dopaminergic midbrain participates in human episodic memory formation: Evidence from genetic imaging. J Neurosci 26(5):1407-1417.
42. Seidman LJ, Valera EM, Makris N. 2005. Structural brain imaging of attention-deficit/hyperactivity disorder. Biol Psychiatry 57(11):1263-1272.
43. Seidman LJ, Valera EM, Makris N, Monuteaux MC, Boriel DL, Kelkar K, Kennedy DN, Caviness VS, Bush G, Aleardi M, et al. 2006. Dorsolateral prefrontal and anterior cingulate cortex volumetric abnormalities in adults with attention-deficit/hyperactivity disorder identified by magnetic resonance imaging. Biol Psychiatry 60(10):1071-1080.
44. Shaw P, Lerch J, Greenstein D, Sharp W, Clasen L, Evans A, Giedd J, Castellanos FX, Rapoport J. 2006. Longitudinal mapping of cortical thickness and clinical outcome in children and adolescents with attentiondeficit/ hyperactivity disorder. Arch Gen Psychiatry 63(5):540-549.
45. Shaw P, Gornick M, Lerch J, Addington A, Seal J, Greenstein D, Sharp W, Evans A, Giedd JN, Castellanos FX, et al. 2007. Polymorphisms of the dopamine D4 receptor, clinical outcome, and cortical structure in attention-deficit/ hyperactivity disorder. Arch Gen Psychiatry 64(8): 921-931.
46. Simon JR, Berbaum K. 1990. Effect of conflicting cues on information processing: The 'Stroop effect' vs. the 'Simon effect'. Acta Psychol (Amst) 73(2):159-170.
47. Sonuga-Barke EJ. 2005. Causal models of attention-deficit/hyperactivity disorder: From common simple deficits to multiple developmental pathways. Biol Psychiatry 57(11):1231-1238.
48. Stroop JR. 1935. Studies of interference in serial verbal reactions. J Exp Psychol 18:643-662.
49. Swanson JM, Kinsbourne M, Nigg J, Lanphear B, Stefanatos GA, Volkow N, Taylor E, Casey BJ, Castellanos FX, Wadhwa PD. 2007. Etiologic subtypes of attention-deficit/hyperactivity disorder: Brain imaging, molecular genetic and environmental factors and the dopamine hypothesis. Neuropsychol Rev 17(1):39-59.
50. Udo de Haes JI, Maguire RP, Jager PL, Paans AML, den Boer JA. 2007. Methylphenidate-induced activation of the anterior cingulate but not the striatum: A [15O] H20 PET study in healthy volunteers. Hum Brain Mapp 28:625-635.
51. Valera EM, Faraone SV, Biederman J, Poldrack RA, Seidman LJ. 2005. Functional neuroanatomy of working memory in adults with attention-deficit/ hyperactivity disorder. Biol Psychiatry 57(5):439-447.
52. Valera EM, Faraone SV, Murray KE, Seidman LJ. 2007. Meta-analysis of structural imaging findings in attention-deficit/hyperactivity disorder. Biol Psychiatry 61(12):1361-1369.
53. van der KooijMA,Glennon JC. 2007. Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder. Neurosci Biobehav Rev 31(4):597-618.
54. van Dyck CH, Malison RT, Jacobsen LK, Seibyl JP, Staley JK, Laruelle M, Baldwin RM, Innis RB, Gelernter J. 2005. Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene. J Nucl Med 46(5):745-751.
55. VanNess SH, Owens MJ, Kilts CD. 2005. The variable number of tandem repeats element inDAT1regulates in vitro dopamine transporter density. BMC Genet 6:55.
56. Volkow ND, Wang GJ, Fowler JS, Gatley SJ, Logan J, Ding YS, Hitzemann R, Pappas N. 1998. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry 155(10):1325-1331.
57. Walter B, Blecker C, Kirsch P, Sammer G, Schienle A, Stark R, Vaitl D. 2003. MARINA: An easy to use tool for the creation of MAsks for Region of INterest Analyses [abstract]. New York, NY: 9th International Conference on Functional. Mapping of the Human Brain.
58. Wechsler D. 1997. Wechsler Adult Intelligence Scale III [manual]. San Antonio, TX: The Psychological Corporation.
59. Yang B, Chan RC, Jing J, Li T, Sham P, Chen RY. 2007. A meta-analysis of association studies between the 10-repeat allele of a VNTR polymorphism in the 3′-UTR of dopamine transporter gene and attention deficit hyperactivity disorder. Am J Med Genet Part B 144B(4):541-550.